Nano Software Services
Market Cap
₹338 Cr.
P/E
31.14

Key Ratios

Market cap
Market cap
338 Cr
PE
PE
31.14
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
182
ROCE (%)
ROCE (%)
13.15
Div Yield (%)
Div Yield (%)
-
Sales
Sales
13.21 Cr
OPM (%)
OPM (%)
-163 %
Debt to Equity
Debt to Equity
-
Institutions
Institutions
0.21 %
Individual < 2 lac
Individual < 2 lac
27.33 %
No. of Shareholders
No. of Shareholders
63,213

About

TAKE Ltd is a healthcare technology and life sciences company providing clinical research, reg… Read more
Low
9
52W Range
High
50
  • Take
  • ABM Knowledgeware
  • HCL Infosystems
  • TJI IT Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

4 Yes

Positive for this company

3 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Verticals

Operating Profit Break-Up

Operational Metrics

    Select a Metric
    • Net Sales by Employee Cost (.)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Customers

    • Abbott India Ltd.
    • Alembic Pharmaceuticals Ltd.
    • Astrazeneca Pharma India Ltd.
    • Cipla Ltd.
    • Dr. Reddy's Laboratories Ltd.

    FAQs on Take Ltd. Business

    TAKE Ltd is a healthcare technology and life sciences company providing clinical research, regulatory, pharmacovigilance, data sciences and AI-driven healthcare solutions. It also develops preventive healthcare and digital health platforms.

    Take major competitors are ABM Knowledgeware, HCL Infosystems, Inspirisys Solutions, CyberTech Sys. &Soft, Equippp SocialImpact, XT Global Infotech, Intense Technologies.
    Market Cap of Take is ₹338 Crs.
    While the median market cap of its peers are ₹376 Crs.

    Take seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material